Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This was the third highest number of inspections per type of company made by the FDA in Missouri, equalling 11.1% of all inspections in the third quarter of 2025.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Bioresearch Monitoring | 1 | — | — |
| Blood and Blood Products | 4 | — | — |
| Compliance: Devices | 1 | — | — |
| Drug Quality Assurance | 1 | — | — |
| Food and Color Additives Petition Review | 1 | — | — |
| Foodborne Biological Hazards | 6 | 1 | — |
| Human Cellular, Tissue, and Gene Therapies | 2 | — | — |
| Monitoring of Marketed Animal Drugs, Feed, and Devices | 2 | — | — |
| Postmarket Assurance: Devices | 1 | — | — |
Alerts Sign-up